Trilobio
PrivateLast Round
Seed
May 6, 2025
Total Funding Raised
$11M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Trilobio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in May 2025.
Trilobio is a biotechnology company that provides a fully automated robotic lab-in-a-box platform designed to improve the efficiency and reproducibility of life science research.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Industrial Robotics, Workflow Automation
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trilobio Comparables
Compare Trilobio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medra | 87% | |
| Robot on Rails | 86% | |
| Biological Lattice Industries | 83% |
For institutional investors. Book with your work email.
Trilobio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trilobio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sequel | Seed |
| Angel Squad | Seed |
| Nucleus Capital | Seed |
| Project 11 Ventures | Pre Seed |
| 1517 Fund | Seed |
| Gaingels | Seed |
| Climate Capital | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Jul 28, 2026
Grew 19% QoQ, from 16 to 19 employees.
For institutional investors. Book with your work email.
Trilobio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trilobio's valuation, stock price, and market status.
Is Trilobio a public or private company?
Trilobio is a private company.
What is the current stock price of Trilobio?
Trilobio is a private company, so its shares have no public market price. Caplight tracks Trilobio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trilobio worth (valuation)?
Valuation information for Trilobio is not publicly available.
Can I buy Trilobio stock?
Trilobio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trilobio's last funding round?
Trilobio's most recent funding round was Seed on May 6, 2025.
Who are the main investors in Trilobio?
Key investors in Trilobio include Lowercarbon Capital, Initialized Capital Management, Argon Ventures.
Will Trilobio IPO soon?
No public IPO plans have been announced for Trilobio.
How can I track Trilobio secondary market activity?
Caplight tracks bids, offers, and trades in Trilobio's shares on secondary markets.